Next Generation Care of HIV/AIDS Patients: Combatting the Effects of HIV-Associated Weight Loss with Anabolic Agents [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

YOU
AT T
AflIBOLIC

ARE C(
'HE 12

ORDIALLY INVITED TO ATTEND A SATELLITE SYMPOSIUM
TH WORLD AIDS CONFERENCE
^\~,

NEXT GENERATION CARE
OF HIV/AIDS PATIENTS:
COMBATING THE EFFECTS OF
HIV-ASSOCIATED WEIGHT LOSS
WITH ANABOLIC AGENTS
WEDNESDAY, JULY 1, 1998
6:30AM - 9:00AM
PALEXPO CONVENTION CENTRE
HALL 5, SESSION HALL 11
GENEVA, SWITZERLAND
SPONSORED AND ACCREDITED BY
DANNEMILLER MEMORIAL
EDUCATIONAL FOUNDATION
THIS PROGRAM IS SUPPORTED BY AN UNRESTRICTED
EDUCATIONAL GRANT FROM BTG PHARMACEUTICALS.

MODERATOR
SHERWOOD L. GORBACH, MD
Professor, Department of Community Health and Family Medicine
Tufts University School of Medicine
Boston, Massachusetts
FACULTY

ALVAN FISHER, MD
Clinical Associate Professor of Medicine
Brown University School of Medicine
Providence, Rhode Island
CARL GRUNFELD, MD, PHD
Professor of Medicine
University of California
San Francisco California

LINDA HELLER, MS, RD, CSP
Nutritionist
Children's, Hospital
Los Angeles, California
MARC K. HELLERSTEIN, MD, PHD
Associate Professor of Nutritional Sciences
University of California
Berkeley, California

FACULTY DISCLOSURE
The Dannemiller Memorial Educational Foundation requires that the faculty participating in a continuing medical educational activity disclose to participants any significant financial interest or other relationship (1) with the manufacturer(s) of
any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation, and (2)
with any commercial supporters of the activity
Sherwood Gorbach, MD reports no relationship. Marc Hellerstein, MD, PhD receives research support and is a member of the
speaker's bureau for BTG Pharmaceuticals. Dr. Hellerstein also is a consultant and member of the speaker's bureau for BristolMyers Squibb. Alvan Fisher, MD receives research support and is a consultant and a member of the speaker's bureau for BTG
Pharmaceuticals. Dr. Fisher also receives research support and is a member of the speaker's bureau for Serono Laboratories.
Linda Heller, MS, RD, CSP is an investigator for BTG Pharmaceuticals. Carl Grunfeld, MD, PhD reports a research grant/contract from BTG Pharmaceuticals and a past research grant/contract from Serono Laboratories and Bristol-Myers Squibb.